Table 3.

Inhibition zone in diameter of pathogenic microbes on agar disc diffusion, KMU, 2020

Scientific name	Concentration		Inhibition zone in diameter (mm)
			Gram positive bacteria				Gram negative bacteria				Fungi
			S. aureus		E. faecalis		E.coli		K. pneumoniae		C. albicans
	Mg/ml	μl/disc	ATCC	MRSA	ATCC	MDR	ATCC	MDR	ATCC	MDR	ATCC	Sample
C. englerianum	100	15	16 ± .0.1	15 ± 0.4	18 ± 0.9	17 ± 1.0	9 ± 0.3	13 ± 1.4	16 ± 2.0	11 ± 0.1	14 ± 1.1	–
		30	24 ± 3.0	25 ± 0.8**	27 ± 1.3	27 ± 1.5#	20 ± 0.7	21 ± 0.2	26 ± 0.8	26 ± 0.9¥	21 ± 0.7	9 ± 0.3
E. depauperata	100	15	15 ± .0.6	14 ± 0.7	16 ± 2.0	17 ± 0.3	–	–	17 ± 0.1	18 ± 0.7	–	10 ± 0.9
		30	23 ± 2.4	23 ± 1.0*	26 ± 0.9	26 ± 0.5#	13 ± 0.1	12 ± 0.4	25 ± 1.2	25 ± 0.7¥	22 ± 1.1	23 ± 0.7
L. adoensis	100	15	16 ± .1.2	12 ± 0.1	11 ± 1.1	14 ± 0.1	10 ± 0.7	14 ± 0.2	20 ± 0.6	20 ± 0.3	–	9 ± 0.3
		30	22 ± 2.4	21 ± 1.8	21 ± 0.5	21 ± 1.5	21 ± 2.1	21 ± 0.3	27 ± 0.1	27 ± 0.7¥	11 ± 0.9	20 ± 0.1
D.penninervi m	100	15	16 ± .0.3	14 ± 0.1	16 ± 0.4	15 ± 0.7	20 ± 0.7	19 ± 1.0	18 ± 0.3	16 ± 0.2	13 ± 0.3	9 ± 1.6
		30	21 ± 0.5	23 ± 2.0*	21 ± 0.1	20 ± 1.0	25 ± 0.8	23 ± 0.1	23 ± 0.7	21 ± 0.4	20 ± 0.9	19 ± 0.4
R. abyssinicus	100	15	14 ± 0.9	9 ± 0.8	15 ± 1.1	11 ± 1.0	–	–	11 ± 1.0	9 ± 0.7	10 ± 0.2	14 ± 0.4
		30	22 ± 0.6	20 ± 0.4	25 ± 0.4	19 ± 1.1	10 ± 0.8	12 ± 0.1	20 ± 0.1	19 ± 0.6	21 ± 0.5	21 ± 0.1
C. pustulatus	100	15	12 ± 1.0	12 ± 0.2	12 ± 0.8	16 ± 1.2	15 ± 0.2	10 ± 0.8	10 ± 0.9	11 ± 0.8	12 ± 0.8	10 ± 0.1
		30	21 ± 0.8	21 ± 0.8	23 ± 0.5	22 ± 0.8#	23 ± 0.4	18 ± 0.9	21 ± 1.0	21 ± 0.4	18 ± 0.1	18 ± 0.8
Modern drug			22 ± 2.0Ce	12 ± 1.9Ce	22 ± 3.0C	13 ± 1.2C	26 ± 2.1C	15 ± 2.3C	24 ± 1.2C	14 ± 1.9C	22 ± 0.3F	21 ± 1.3F

Mean ± SD, NT Not tested, − = No inhibition zone, C Ciprofloxacin, Ce Cefoxitin, F Ketoconazole, MDR < 16 mm, ATCC > 21 mm *P < 0.05, **P < 0.01 compared to cefoxitin treated MRSA. ^#P < 0.05 compared to modern drug treated E. faecalis, ^¥ P < 0.05 compared to modern drug treated K. pneumoniae